Edition:
United Kingdom

Apellis Pharmaceuticals Inc (APLS.OQ)

APLS.OQ on NASDAQ Stock Exchange Global Select Market

18.88USD
18 Apr 2019
Change (% chg)

$0.23 (+1.23%)
Prev Close
$18.65
Open
$18.66
Day's High
$18.92
Day's Low
$18.37
Volume
72,626
Avg. Vol
113,307
52-wk High
$26.56
52-wk Low
$11.45

About

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit complement component 3 (C3), the central protein in the complement cascade. The... (more)

Overall

No Ratios Available.

Financials

  APLS.OQ Industry Sector
P/E (TTM): -- 29.30 32.55
EPS (TTM): -- -- --
ROI: -- 14.23 13.83
ROE: -- 15.46 15.25

Earnings vs. Estimates